期刊文献+

2009-2014年某综合医院鲍曼不动杆菌的耐药分析 被引量:1

The Drug-resistant Characteristics of Acinetobacter Baumannii Isolated from a General Hospital in 2009-2014
下载PDF
导出
摘要 目的:分析2009-2014年中山大学附属惠州医院临床分离鲍曼不动杆菌的分布特征及耐药性演变。方法:收集中山大学附属惠州医院2009-2014年临床分离的1746株鲍曼不动杆菌,用VITEK2系统进行细菌鉴定;AST GN16药敏板进行MIC药敏试验;用WHONET5.6软件结合医院临床病案系统分析耐药性。结果:自2011年来,鲍曼不动杆菌检出率逐年增加,主要集中在ICU、儿科、神经外科及呼吸内科病房的呼吸道标本;鲍曼不动杆菌对常用抗生素耐药性呈上升趋势,其中ICU对亚胺培南耐药率逐年上升明显,2013-2014年,ICU病房亚胺培南耐药率分别达到了75.0%和68.6%。结论:2009-2014年本院鲍曼不动杆菌对常用抗生素的耐药性增加明显,ICU鲍曼不动杆菌菌株的耐药率明显高于全院平均水平,亚胺培南耐药问题严峻。 Objective: To analyze the clinical distribution and drug-resistant characteristics of acinetobacter baumannii isolated from Huizhou Central Affiliated hospital of Sun Yat-sen University during 2009-2014.Method: 1746 acinetobaeter baumannii strains were isolated from our hospital during 2009-2014. The bacteria were identified by VITEK2 compact system, the minimum inhibitory concentration(MIC) was determined by AST GN16 drug sensitive plate, the results were analyzed by WHONETS.6 software.Result: Since 2011, the detection rate of acinetobaeter baumannii increased year by year, which mainly were the respiratory specimen of patients in ICU, pediatrics, neurosurgery and department of respiratory medicine.Acinetobacter baumannii showed increasing drug- resistant to almost all of the antibiotics, the imipenern resistance had increased year by year, imipenem resistance of the ICU in 2013 and 2014 were 75.0% and 68.6% , respectively.Conclusion: The isolates of our hospital showed high drug-resistant to all kinds of antibiotics during 2009-2014, especially those strains isolated from ICU.Imipenem resistance has become a severe problem.
出处 《中外医学研究》 2016年第15期72-74,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
基金 广东省惠州市科技局基金资助项目(项目编号:20150801)
关键词 鲍曼不动杆菌 耐药性 抗菌药物 Acinetobacter baumannii Drug resistance Antibiotic drug effects
  • 相关文献

参考文献13

  • 1Dijkshoorn L, Nemec A, Seifert H.An increasing threat in hospitals: muhidrug-resistant Acinetobacter baumannii[J].Nat Rev Microbiol, 2007, 5(12): 939-951.
  • 2陈佰义,何礼贤,胡必杰,倪语星,邱海波,石岩,施毅,王辉,王明贵,杨毅,张菁,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学,2012,2(8):3-8. 被引量:518
  • 3张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 4习慧明,徐英春,朱德妹,汪复,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳,俞云松,杨青.2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):98-104. 被引量:212
  • 5胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
  • 6汪复,朱德妹,胡付品,蒋晓飞,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330. 被引量:466
  • 7胡付品,朱德妹,汪复,蒋晓飞,孙自镛,陈中举,胡志东,李金,谢轶,康梅,徐英春,张小江,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,储云卓,田素飞,徐元宏,沈继录,单斌,杜艳,卓超,苏丹虹,张泓,孔菁,魏莲花,吴玲,胡云建,艾效曼.2013年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2014,14(5):365-374. 被引量:624
  • 8Jamulitrat S, Arunpan P, Phainuphong P.Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection[J].J Med Assoc Thai, 2009, 92(3): 413-419.
  • 9Hornsey M, Loman N, Wareham D W, et al.Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, whereresistance developed during tigecycline therapy[J].J Antimicrob Chemother, 2011, 66(7): 1499-1503.
  • 10Sun Y, Cai Y, Liu X, et al.The emergence of clinical resistance to tigecycline[J].Int J Antimicrob Agents, 2013, 41(2): 110-116.

二级参考文献98

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial susceptibility testing~ twentieth information- al supplement[S]. CLSI, 2010,30 ( 1 ) : M100-S20.
  • 3Peleg AY, Seifert H, Paterson DL. Acinetobacterbauman- nil: emergence of a successful pathogen[J]. Clin Microbiol Rev,2008,21(3) :538-582.
  • 4Choi WS, Kim SH, Jeon EG, et al. Nosoeomial outbreak of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units and successful outbreak control program[J]. J Korean Med Sci,2010, 25(7) :999-1004.
  • 5NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992through June 2003, issued August 2003 [J]. Am J Infect Control, 2003,31 (8) : 481 498.
  • 6Karageorgopoulous DE, Falagas ME. Current control and treatment of multidrug-resistant aclnetobacter baumannii in- fections[J]. Lancet Infect Dis, 2008,8 (12): 751-762.
  • 7Perez F, Hujer AM, Hujer KM, et al. Global Challenge of multidrug-resistant Acinetobacter baumannii [ J ]. Antimicrob Agents Chemother, 2007,51 (10) : 3471-3484.
  • 8Y Doi, Husain S, Potoski BA, et al. Extensively drug-resist- ant Acinetobacter baumannii [J ]. Emerg Infect Dis, 2009,15 (6):980-982.
  • 9Bassetti M, Righi E, Esposito S, et al. Drug treatment for multidrug-resistant Acinetobacter baumannii infections [J]. Future Microbiol, 2008,3 (6) .. 649-660.
  • 10Durante-Mangoni E, Zarrilli R. Global spread of drug-resist- ant Acinetobacter baumannii molecular epidemiology and management of antimicrobial resistance[J]. Future Microbi- ol,2011,6(4) :407-422.

共引文献2134

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部